Research Continuity

The University has approached reopening its laboratories, core facilities, and studios in a phased manner in accordance with key principles. Although conditions have steadily improved, the University may make changes to this guidance at short notice. Therefore, researchers are encouraged to check this page often and to sign up for the update mailing list here.

The University is operating in Phase 4 for research labs, studios, and core facilities.

In Phase 4, Notre Dame has returned to full research operations with few to no limitations. Lab directors, departments, or colleges are allowed to make more restrictive local protocols in consultation with the VPR.

Continuation of Phase 3.1 Pilot Program

In Phase 3.1, the University announced a pilot program that included required surveillance testing for the summer. Part of the motivation of the testing program was to monitor the presence of the virus on campus and learn lessons of how Notre Dame may manage campus this fall when the population is larger and there are new possible challenges (e.g. new variants and possible limitations of immunity). 

Therefore, as part of Phase 3.1, the surveillance testing program will continue this summer. Testing is open Monday thru Thursday from 9 a.m. to 1 p.m. To schedule your testing day, please click here. Please note, your name must be submitted on the Phase 3.1 form in order to schedule testing.

Those who test at least seven weeks this summer (ending August 12, 2021) will receive $25 Domer Dollars, transferred into your account. All who complete the seven weeks of testing will also be given a chance to win a pair of tickets to an ND football game; a drawing will be held for each of this year’s seven games, with each game’s winner selected from the eligible participants

If updates to the lab roster need to be made throughout the summer, please resubmit a new Phase 3.1 form here

ABOUT THIS PAGE

This page provides information on the University's response to the COVID-19 pandemic as it relates to research laboratories, studios, and core facilities. It is organized into the following key sections:

PHASE 4 GENERAL GUIDELINES

This information is provided to help answer questions researchers may have about critical laboratory and facility functions or the impact on ongoing or forthcoming research projects during the Phase 3.1 response to the COVID-19 pandemic. 

  • People should not come to campus if they have any symptoms of COVID-19.
  • All researchers who come to campus are required to adhere to the University's COVID-19 policies. For full guidance, please visit covid.nd.edu.
    • Research Directors have the responsibility to train their research team members in these processes and procedures and ensure that guidelines and University directives are followed.
    • In some cases, a student, staff member, or faculty member may be granted accommodation for health reasons. Directors must establish protocols for these accommodations. 
  • Masks are required indoors for the unvaccinated. Those individuals should also sign up for weekly surveillance testing. 
    • Those who are fully vaccinated by one of the three vaccines approved in the United States (Johnson & Johnson, Moderna, or Pfizer-BioNTech) do not need to wear their masks indoors.
    • Those who are vaccinated may choose to wear masks as a matter of personal safety. 
    • Individuals working with flammable materials are not required to wear a mask while working at a negative pressure hood. However, if you are unvaccinated and wearing a mask in this area, a flame retardant one is encouraged. 
    • Faculty, staff, and students working in the IU School of Medicine buildings south of campus, Harper Hall and Raclin Carmichael Hall, must follow these guidelines: 
      • All building occupants, regardless of institutional affiliation, must wear a mask in common spaces.  The common spaces include hallways, restrooms, break rooms, shared research spaces, etc.
      • Notre Dame personnel in Notre Dame only spaces are not required to wear a mask if they are vaccinated. Unvaccinated individuals are asked to continue to wear a cloth mask for their own safety and the safety of others.
      • IUSM personnel are still required to wear masks, per the IU guidelines
      • In research spaces where there is shared usage (e.g. tissue culture rooms or core facilities), appropriate face coverings must be worn. If more than 3 feet of distance cannot be maintained in these shared spaces, Notre Dame personnel must wear surgical masks.
  • Equipment and furnishings must be disinfected before and after use.
  • All shared kitchenettes must be cleaned and disinfected after each use.
  • Outdoor breaks are encouraged.
  • There are no specified occupancy protocols of office-like spaces (e.g. offices, conference rooms, and gathering spaces).
  • All faculty and staff are required to be vaccinated against COVID-19 and provide verification of full vaccination no later than August 2, 2021. View Indiana and Michigan relevant vaccination websites.
  • Graduate, professional, and undergraduate students on-campus for seven or more consecutive days or regularly working in a lab/studio/core facility during the summer are required to be vaccinated. 
    • The University will require all students to be fully vaccinated before arriving on campus for the 2021 summer sessions and the 2021-22 academic year.
  • Feedback regarding the incidence of positive cases in the labs/studios/core facilities follows the same contact tracing and quarantine protocols that have been employed to date.

ADDITIONAL SPECIFIC INFORMATION

Additional guidance and information that relate to conducting research can be found below.

FORMS

Relevant forms can be found below.

LAB/STUDIO/CORE FACILITY REOPENING 

Please use the form below to submit the roster of the members of your lab, including incoming students who may not have arrived yet. This form should only be completed by each research director or designated assistant or lab member. Please note, a designate may complete the form; however, it is the director's responsibility to decide if moving to this phase.

If updates to the lab roster need to be made throughout the summer, please resubmit a new Phase 3.1 form.

RESEARCH TRAVEL 

Before scheduling travel, please review the University’s Summer Travel Policy.

VISITORS TO THE ACADEMY AND GROUP GATHERINGS

Please review the University's Summer Visitor Policy and Gathering Policy when planning for visitors or groups on-campus.

Report a Reopening of Research Concern

REPORT A RESEARCH CONCERN

The above form can be submitted anonymously if preferred. All feedback is reviewed and addressed by the Research Ombudsperson for Reopening, Melanie DeFord

Need More Information?

For the latest information regarding the University’s response to the COVID-19 pandemic, please visit covid.nd.edu.

Announcements of research reopening updates are emailed to a lab reopening Google Group mailing list. To opt-in to this mailing list, please subscribe here. Your ND email address must be used in order to opt-in. 

For additional guidance, please communicate with your Department Chair or, if needed, a relevant member of the Subtask Force on Research Laboratory Operations. Members include Jim BrockmoleSteve CorcelliMelanie DeFord, and Mark McCready.

If you are unsure who to contact, please email research@nd.edu and your query will be forward, as appropriate.